Men's Health News

RSS

Men are not better at quitting smoking than women according to new study

There is “no convincing evidence” that men are better than women at quitting smoking, finds research published online in Tobacco Control.

31 May 2012

Exelixis commences cabozantinib phase 3 pivotal trial in mCRPC

Exelixis, Inc. today announced the initiation of COMET-1, a phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer.

31 May 2012

For many prostate cancer patients, new guidance is confusing

The recommendation that fewer men get screened for the disease goes against what many people believe should be appropriate, NPR reports.

30 May 2012

IU scientists focus on health issues and behaviors specific to bisexual men and women

Bisexuality, often stigmatized, typically has been lumped with homosexuality in previous public health research. But when Indiana University scientists recently focused on the health issues and behaviors specific to behaviorally bisexual men and women, they found tremendous variety, and that commonly used labels, such as heterosexual and homosexual, can sometimes do more harm than good.

30 May 2012

Cabazitaxel offers added benefit for men with metastatic prostate cancer

Cabazitaxel has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.

30 May 2012

PKCZ protein could serve as new treatment target for prostate cancer

A newly-discovered protein found only in prostate cancer cells could be used as a marker of the disease and offer a new treatment target, according to a study in the British Journal of Cancer.

30 May 2012

Women and men not receiving effective diagnostic testing and treatments for osteoporosis

Women and men are not receiving effective diagnostic testing and treatments of osteoporosis, a life threatening condition affecting millions of Americans, according to an expert today at the American Association of Clinical Endocrinologists (AACE) 21st Annual Meeting & Clinical Congress in Philadelphia.

28 May 2012

X-chromosome involved in development of bowel cancer

Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.

28 May 2012

Hearing loss linked to several chronic diseases

The Better Hearing Institute (BHI) is raising awareness of the link between hearing loss and some chronic diseases during National Men's Health Week (June 11 – 17).

25 May 2012

DiagnoCure’s PCA3 prostate cancer diagnostic test showcased at AUA meeting

DiagnoCure Inc., a Quebec life sciences company that develops and commercializes high-value cancer diagnostic tests, reported that the PROGENSA PCA3 prostate cancer diagnostic test has been featured in a number of presentations and discussions at the American Urological Association (AUA) meeting in Atlanta, GA.

25 May 2012

Doctors disagree on new prostate cancer screening guidelines

One doctor suggests the problem is the rush to treatment, not the screening; another suggests that a failure to screen men could be more costly in the long run.

25 May 2012

Oestrogen promotes presence of 'mucoid' form of P. aeruginosa in women with CF

Researchers from the Respiratory Research Division of the Department of Medicine, Royal College of Surgeons in Ireland (RCSI) have published a study which represents a major breakthrough in understanding why females with cystic fibrosis do worse than males.

25 May 2012

Scientists discover key gene essential for sperm development

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

25 May 2012

Auxilium, FCB I file suit against Watson over generic Testim

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.

25 May 2012

Cancer diagnosis may increase risk of death in men with mental illness

Men suffering from psychiatric problems when diagnosed with cancer are more likely to die from the disease, according to a new study published today in the British Journal of Cancer.

24 May 2012

Breakthrough in understanding the causes of unexplained male infertility

The diagnosis of male fertility is usually performed through the observation of the sperm in the microscope. However, a normal quality semen does not guarantee an adequate fertility. In fact, there is a considerable proportion of cases of unexplained infertility and data suggest that abnormal sperm function may have a genetic or molecular origin.

24 May 2012

CMS sticks with Medicare coverage of PSA test

The federal government is not changing coverage plans "at this time." Meanwhile, a number of urologists and other medical specialists raise concerns that new recommendations against prostate cancer screening will hurt men's health.

24 May 2012

Viewpoints: The promise and perils of prostate screening; Presidential candidates shy away from frank discussion of spending

After an exhaustive process, the U.S. Preventive Services Task Force has announced its final recommendation on PSA-based prostate cancer screening. It finds that the known harms of screening outweigh the potential benefits for men who have no cancer symptoms. It notes that all screening studies have demonstrated considerable harms associated with screening, but only one major study found evidence that screening saves lives -- and that study has some internal inconsistencies.

24 May 2012

Federal task force recommends dropping routine prostate cancer test

The U.S. Preventive Services Task Force finds scant evidence that the PSA blood test saves lives and instead says unneeded treatment leads to serious problems, including impotence and incontinence.

23 May 2012

Article examines reasons why people are so reluctant to give up PSA test

The uproar that began last year when the U.S. Preventive Services Task Force stated that doctors should no longer offer regular prostate-cancer tests to healthy men continued this week when the task force released their final report. Overall, they stuck to their guns, stating that a blood test commonly used to screen for prostate cancer, the PSA test, causes more harm than good - it leads men to receive unnecessary, and sometimes even dangerous, treatments.

23 May 2012